Details of the Drug
General Information of Drug (ID: DM98MXT)
| Drug Name |
[2-(Benzoimidazol-1-yl)ethyl]-bisphosphonic acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
CHEMBL457423; AC1NQQY7; [2-(Benzoimidazol-1-yl)ethyl]-bisphosphonic acid; [2-(benzoimidazol-1-yl)ethylidene]bisphosphonic acid; SCHEMBL20385726; BDBM50273716; 847738-31-2; [2-(benzimidazol-1-yl)-1-phosphonoethyl]phosphonic acid; Phosphonic acid, [2-(1H-benzimidazol-1-yl)ethylidene]bis-; [2-(benzimidazol-1-yl)-1-phosphono-ethyl]phosphonic acid
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 306.15 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -2.1 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 7 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


